PDRN. Proven in a needle. Promised in a bottle.

If you bought a PDRN serum in the last year, you bought something that started its life as a prescription drug. The ingredient is a fragment of DNA from salmon sperm. Italy approved the first injectable version of it in 1994 for wound healing. South Korea approved it later and built an aesthetic industry around it. Today, dermatologists in Seoul inject it into the faces of women who want to rebuild collagen without fillers. A 2024 survey of Korean dermatologists who use injectable skin boosters found that eighty-eight percent of them had adopted it in their practice. The molecule in the bottle on your counter is the same category of compound they are injecting. What happens next is where the two versions stop being the same story.

When a dermatologist injects PDRN into the skin, the fragment of salmon DNA lands in the dermis, the layer where your collagen and elastin live. There, it activates a receptor your skin already has, and your own cells respond. They produce more collagen. They reduce inflammation. They build new blood vessels under the surface of the skin. This is why the treatment has become one of the most popular injectable boosters in South Korea. It is also why a 2014 trial of diabetic patients with foot ulcers found that PDRN injections nearly doubled the healing rate compared to a placebo. The research on the injection is not perfect. The independent systematic reviews say the existing studies are small and the quality is mixed. But the evidence exists, and it has existed for a long time.

The serum is a different question. When you apply it to your skin in the morning, the molecule has to cross something your dermatologist does not have to worry about. It is called the stratum corneum, and it is the top layer of your skin. Its job is to keep the outside world out. It is very good at its job. Most molecules the size of PDRN cannot get through it. In a clinic, the needle bypasses this layer completely and delivers the molecule straight to the dermis. In your bathroom, the serum has to convince the stratum corneum to let it through, and the evidence that it does is much smaller than the evidence that the injection works.

So what does the evidence for the serum actually show? In October 2025, a Chinese research group published a study testing a PDRN eye cream on thirty-three women over twenty-eight days. Each woman used the PDRN cream on one side of her face and a placebo cream on the other. After four weeks, the PDRN side showed measurable improvements in fine lines, dermal density, under-eye puffiness, and skin brightness. The researchers used real instruments and real measurements. They concluded that the cream worked. But most of the researchers were employed by companies with a commercial interest in the outcome, and the placebo itself was a moisturizer. The study is the best clinical evidence that currently exists for topical PDRN on intact skin. It is also thirty-three women, twenty-eight days, and one trial.

So does the serum work?

The honest answer is that nobody knows yet. The molecule is real. The injection has thirty years of evidence behind it. The serum has one 28-day study, run by people who sell the product, compared against a moisturizer. That is not proof the serum does nothing. It is proof that the science has not caught up to the label.

Here is what that means for you. If your serum makes your skin feel better, it probably is making your skin feel better, the way a good moisturizer does. Whether the PDRN inside it is doing anything extra, on top of that, is the question the industry has not answered. Maybe it is. Maybe it is not. The thirty-two years of evidence behind the needle are not yet behind the bottle, and no amount of marketing can shorten that distance.

The next time you see a PDRN serum, you will know how to read it. You will know what it is made of. You will know what it can and cannot prove about itself. You will know the difference between a molecule that has been tested and a label that has been printed. That is the whole point of knowing.